Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04043312 · ClinicalTrials.gov registry record · NA
Magnetic Stimulation to Treat VT Storm
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04043312: Completed NA study, sponsored by University of Pennsylvania.
NCT04043312 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04043312, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Ventricular Tachycardia storm is a medical emergency characterized by three or more episodes of ventricular arrhythmia within 24 hours and associated with a significantly increased mortality and massive health resource utilization. Several therapies are utilized including sympathetic blockade (through deep sedation and beta blockers), antiarrhythmic drugs, implantable cardioverter defibrillator (ICD) reprograming where applicable, and catheter ablation. Despite standard intervention, mortality rates remain high and additional therapeutic options are actively being investigated. The overall objective of this proposal is to investigate whether transcutaneous magnetic stimulation designed to inhibit the left stellate ganglion can be used in this population. This is a single-center, randomized, sham-controlled trial to assess the efficacy of transcutaneous magnetic stimulation of the left stellate ganglion to treat patients with ventricular tachycardia storm.
Interventions
- DEVICE Magstim SuperRapid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04043312
The ClinicalTrials.gov registry entry for NCT04043312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magstim SuperRapid is the first listed.
NCT04043312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04043312 about?
NCT04043312 is a clinical study titled "Magnetic Stimulation to Treat VT Storm". Ventricular Tachycardia storm is a medical emergency characterized by three or more episodes of ventricular arrhythmia within 24 hours and associated with a significantly increased mortality and massive health resource utilization. Several therapies are utilized including sympathetic blockade (throu...
What is the current status of trial NCT04043312?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-08-14. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT04043312?
The interventions under investigation include: Magstim SuperRapid (DEVICE).
Who is sponsoring clinical trial NCT04043312?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.